Nanobiotix SA (NBTX) Earnings Date & Reports

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NBTX is expected to report earnings to rise 42.90% to -73 cents per share on April 02

Nanobiotix SA NBTX Stock Earnings Reports

Q4'24

Est.

$-0.73

Q2'24

Est.

$-0.51

Q4'23

Beat

by $0.75

The last earnings report on September 18 showed earnings per share of -51 cents, missing the estimate of -50 cents. With 2.93K shares outstanding, the current market capitalization sits at 166.36M.

View a ticker or compare two or three

Compare

NBTX